Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2014
06/26/2014WO2014097209A1 A pharmaceutical composition containing candesartan cilexetil and amlodipine
06/26/2014WO2014096984A1 Stable pharmaceutical composition of sodium oxybate
06/26/2014WO2014096983A1 Stable pharmaceutical compositions of saxagliptin or salts thereof
06/26/2014WO2014096982A1 Stable pharmaceutical compositions of saxagliptin or salts thereof
06/26/2014WO2014096828A1 Pharmaceutical formulation of n- [5- [2-(3,5-dimethoxyphenyl) ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl] benzamide
06/26/2014WO2014096740A1 Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum
06/26/2014WO2014096669A1 Orodispersible tablets obtained by compression moulding
06/26/2014WO2014096622A1 Active ingredient microparticles
06/26/2014WO2014096491A1 Nanocapsules of protamine
06/26/2014WO2014096485A1 Oral pharmaceutical composition for drugs with a high-dosage regimen
06/26/2014WO2014096454A1 Soluble, dispersible or orodispersible tablets comprising cyclophosphamide
06/26/2014WO2014096387A1 Solid unit with high fexofenadine content and process for the preparation thereof
06/26/2014WO2014096277A1 Tablet composition comprising cinacalcet hydrochloride
06/26/2014WO2014096257A1 Freeze-dried cross-linked hyaluronic acid sponge
06/26/2014WO2014096209A1 A pharmaceutical formulation comprising inositol and selenium, preparation and use thereof
06/26/2014WO2014096139A1 Solid oral dosage form of testosterone derivative
06/26/2014WO2014096124A1 Film coated pellets
06/26/2014WO2014096116A1 Pharmaceutical formulation comprising ciclesonide
06/26/2014WO2014096115A1 Ciclesonide for the treatment of airway disease in horses
06/26/2014WO2014096032A1 Gm-csf for treatment of chronic sinusitis
06/26/2014WO2014095953A1 Dialysis composition
06/26/2014WO2014095924A1 Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in the treatment of inflammatory or respiratory tract diseases
06/26/2014WO2014095845A1 Tablets with improved acceptance and good storage stability
06/26/2014WO2014095818A1 Formulation comprising amorphous agomelatine
06/26/2014WO2014095705A1 Gel compositions
06/26/2014WO2014095628A1 Oral formulation containing a statin in omega-3 polyunsaturated fatty acids (n-3 pufa)
06/26/2014WO2014095625A1 Anti-dandruff composition
06/26/2014WO2014095602A1 Combination of levocabastine and fluticasone furoate for the treatment of inflammatory and/or allergic conditions
06/26/2014WO2014095576A1 Salipro particles
06/26/2014WO2014095485A1 Silymarin aqueous formulation
06/26/2014WO2014094956A1 Magnesium hydroxide carbonate as excipient in pharmaceutical preparations, having improved release of active ingredient
06/26/2014WO2014094921A1 Curcumin solubilisate
06/26/2014WO2014094632A1 Pharmaceutical composition for treating headache, and preparation method thereof
06/26/2014WO2014094087A1 Polymer nanoparticles containing amitraz and/or fluazuron, production method, formulation and uses
06/26/2014WO2014094085A1 Method for obtaining chitosan-based products enriched with arrabidaea chica
06/26/2014WO2014074797A8 Ultra low density pulmonary powders
06/26/2014WO2014054978A3 Stable combined solution of fenoterol hydrobromide and ipratropium bromide
06/26/2014WO2014047150A3 Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
06/26/2014WO2013090891A8 Controlled release vehicles having desired void volume architectures
06/26/2014US20140180224 Composition, device and method for delayed and sustained release of brain energy molecules
06/26/2014US20140180223 Transparent transdermal nicotine delivery devices
06/26/2014US20140180201 Microarray for delivery of therapeutic agent and methods of use
06/26/2014US20140179982 Magnetic diffusional patch
06/26/2014US20140179825 Methods Of Manufacturing Contact Lenses For Delivery Of Beneficial Agents
06/26/2014US20140179803 Continuous flow production of gelatin nanoparticles
06/26/2014US20140179802 Fiber comprising a biodegradable polymer
06/26/2014US20140179797 Composition for Administering an NMDA Receptor Antagonist to a Subject
06/26/2014US20140179793 Methods of treating neurodegeneration caused by iron accumulation in the brain comprising administering metal chelators to the upper one-third of the nasal cavity
06/26/2014US20140179792 Method of treating lewy body syndrome with comprising administering metal chelators to the upper one-third of the nasal cavity
06/26/2014US20140179791 Method of treating progressive supranuclear palsy comprising administering metal chelators to the upper one-third of the nasal cavity
06/26/2014US20140179790 Method of treating traumatic brain injury/head injury comprising administering metal chelators to the upper one-third of the nasal cavity
06/26/2014US20140179789 Methods of treating huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavity
06/26/2014US20140179749 Formulations of enzalutamide
06/26/2014US20140179745 Topical ophthalmological pharmaceutical composition containing regorafenib
06/26/2014US20140179740 Stable liquid remifentanil formulations
06/26/2014US20140179739 Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
06/26/2014US20140179734 Adhesive skin patch containing serotonin receptor antagonist drug
06/26/2014US20140179731 Tacrolimus For Improved Treatment Of Transplant Patients
06/26/2014US20140179729 Oral dosage forms for oxygen-containing active agents and oxyl-containing polymer
06/26/2014US20140179721 Solid pharmaceutical dosage form
06/26/2014US20140179719 Novel amorphous solid dispersions of valganciclovir hydrochloride
06/26/2014US20140179706 Fluoroergoline derivatives and uses thereof
06/26/2014US20140179703 Concentrated methotrexate solutions
06/26/2014US20140179683 Sustained-release preparation of ivabradine or pharmaceutically acceptable salts thereof
06/26/2014US20140179653 Non-mucoadhesive film dosage forms
06/26/2014US20140179597 Method for the treatment and prevention of Alzheimer's disease and central nervous system dysfunction
06/26/2014US20140178485 Active agent microparticles
06/26/2014US20140178484 Multi-particulate pharmaceutical composition
06/26/2014US20140178479 Concentrated Felbamate Formulations for Parenteral Administration
06/26/2014US20140178477 Solid preparation
06/26/2014US20140178476 Highly Efficient Delivery of a Large Therapeutic Mass Aerosol
06/26/2014US20140178473 Solid dosage form
06/26/2014US20140178471 Multi-layered release formulation
06/26/2014US20140178470 Dispersible tablet
06/26/2014US20140178469 Stable benzimidazole formulation
06/26/2014US20140178468 Multiparticulate extended-release composition of mesalamine
06/26/2014US20140178467 Capsule and powder formulations containing lanthanum compounds
06/26/2014US20140178465 Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury
06/26/2014US20140178462 Amphoteric liposomes comprising neutral lipids
06/26/2014US20140178459 Compositions and methods for transdermal delivery of hormones and other medicinal agents
06/26/2014US20140178458 Medicinal skin protection composition with an active ingredient combination which improves the skin barrier
06/26/2014US20140178457 Binder and process for producing fabrics containing cyclodextrins fixed by said binder
06/26/2014US20140178456 Methods and compositions for treating type 2 diabetes and related conditions
06/26/2014US20140178450 Compositions and Methods for Tissue Repair with Extracellular Matrices
06/26/2014US20140178448 Continuous culturing device
06/26/2014US20140178440 Transmucosal drug delivery devices for use in chronic pain relief
06/26/2014US20140178357 Stabilized liquid and lyophilized adamts13 formulations
06/26/2014US20140178347 Nutritional supplement system
06/26/2014US20140178331 Method of treating cerebral hemorrhage and subarachnoid hemorrhage comprising administering metal chelators to the upper one-third of the nasal cavity
06/26/2014US20140178311 Method of adding botanical agents/dietary supplements to pharmaceutical agents in a pharmacotherapeutic regimen
06/26/2014US20140175686 Poorly Soluble Drug Containing Microspheres With Improved Bioavailability And Method Of Preparing The Same
06/26/2014US20140174437 Dry powder inhaler and methods of use
06/26/2014DE112012001286T5 Sternpolymer-Nanoschalen und Verfahren zur Herstellung derselben Star polymer nanoshells and methods for making the same
06/26/2014DE102013000586A1 Active substance-containing nanoparticles useful e.g. for topical application on pharyngeal mucosa, comprise carrier or matrix material, dispersant, first active substance, and second active substance comprising acidic glycosaminoglycan
06/26/2014DE102012025485A1 Neuartige Vesikel für die topische Anwendung in der Pharmazie und Kosmetik Novel vesicles for topical application in the pharmaceutical and cosmetics
06/25/2014EP2746396A1 Selective local inhibition of TNFR1-mediated functions at the site of antigen/allergen presentation
06/25/2014EP2746291A2 Pulmonary formulation comprising an immunoglobulin single variable domain which binds to TNFR1
06/25/2014EP2746290A2 Polypeptides, antibody variable domains and antagonists
06/25/2014EP2745849A1 Polydeoxyribonucleotides composition and uses thereof
06/25/2014EP2745848A1 Orally disintegrating tablet containing hydroxyalkyl cellulose fine particles
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 2991